The table below shows ABEONA THERAPEUTICS INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$8.72M
-
$400.00K
-
-
-
Cost of revenue
$2.70M
$488.00K
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$9.55M
$4.22M
$5.94M
$9.94M
$8.94M
$9.22M
SG&A
ABEO annual revenue (10-K history)
ABEONA THERAPEUTICS INC. reported annual revenue of $5.82M for fiscal year 2025. That is up 66.3% from $3.50M in fiscal 2023. Over the 10 fiscal years shown, annual revenue grew from $925.00K (FY 2014) to $5.82M. Figures come from the company's audited annual reports as filed with the SEC.